SEC 13F Intelligence

Vivo Capital, LLC / VRNA

Vivo Capital, LLC’s Verona Pharma PLC Position

Does Vivo Capital, LLC own Verona Pharma PLC (VRNA)? Not currently — the last reported position was 1.39M shares worth $149M in Q3 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$149M
Q3 2025
Shares
1.39M
% of Portfolio
+11.97%
Quarters Held
26
position exited

Position History VRNA

Reported value by quarter
Q4 ’18: $13MQ4 ’18Q1 ’19: $10MQ2 ’19: $8MQ1 ’20: $6MQ2 ’20: $7MQ2 ’20Q3 ’20: $7MQ4 ’20: $21MQ1 ’21: $25MQ2 ’21: $20MQ2 ’21Q3 ’21: $15MQ4 ’21: $18MQ1 ’22: $14MQ2 ’22: $12MQ2 ’22Q3 ’22: $43MQ4 ’22: $3,637Q1 ’23: $85MQ2 ’23: $90MQ2 ’23Q3 ’23: $69MQ4 ’23: $84MQ1 ’24: $58MQ2 ’24: $51MQ2 ’24Q3 ’24: $102MQ4 ’24: $106MQ1 ’25: $91MQ2 ’25: $132MQ2 ’25Q3 ’25: $149Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q3 20251.39M$149M+11.97%
Q2 20251.39M$132M+13.49%
Q1 20251.44M$91M+12.10%
Q4 20242.28M$106M+11.88%
Q3 20243.55M$102M+8.45%
Q2 20243.55M$51M+4.74%
Q1 20243.61M$58M+4.56%
Q4 20234.25M$84M+6.92%
Q3 20234.25M$69M+7.59%
Q2 20234.25M$90M+6.20%
Q1 20234.25M$85M+5.92%
Q4 20224.25M$3,637+0.42%
Q3 20224.25M$43M+4.80%
Q2 20222.75M$12M+1.16%
Q1 20222.75M$14M+0.94%
Q4 20212.75M$18M+1.11%
Q3 20212.75M$15M+0.68%
Q2 20213.05M$20M+0.86%
Q1 20213.05M$25M+0.90%
Q4 20203.05M$21M+0.95%
Q3 20201.49M$7M+0.50%
Q2 20201.49M$7M+0.50%
Q1 20201.49M$6M+0.56%
Q2 20191.49M$8M+0.71%
Q1 20191.49M$10M+0.97%
Q4 20181.49M$13M+1.72%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Vivo Capital, LLC’s full portfolio or all institutional holders of VRNA.